Rob Willemsen

Rob Willemsen is an Associate Professor in the Department of Clinical Genetics at Erasmus MC, a leading academic medical center in the Netherlands. His research is centered on the molecular and genetic basis of neurodevelopmental and inherited disorders, with a focus on fragile X syndrome and related conditions. He employs advanced models such as zebrafish and in vivo systems to investigate gene regulation, methylation dynamics, and disease mechanisms.

His research interests span clinical genetics, molecular genetics, neurodevelopmental disorders, epigenetic regulation, and rare genetic diseases. Using zebrafish models, he explores gene function and pathogenic variants associated with conditions like pediatric cardiomyopathy, hereditary spastic paraplegia, and refractive errors. His work often bridges basic science with translational applications, including drug testing in preclinical models.

The trends in his recent publications indicate a strong focus on gene discovery, functional genomics, and therapeutic intervention for monogenic disorders. His studies frequently involve international collaborations and multidisciplinary teams, leveraging high-throughput sequencing, transcriptomics, and animal modeling to validate candidate genes from GWAS and clinical findings.

Rob Willemsen has supervised 14 research projects, indicating an active role in mentoring students and junior researchers. He has received significant attention for his work, with mentions in news outlets and citations in major journals, though specific grants or funding sources are not detailed in the text. His collaborations span multiple institutions and countries, reflecting a broad scientific network.

His research is conducted within the Clinical Genetics department at Erasmus MC, where he contributes to both fundamental research and potential clinical applications. While no specific lab name is mentioned, his work involves molecular and cellular analysis, animal models, and collaboration with clinical teams to translate findings into patient care.